Factor XII (Hageman Factor)
Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III.
Also Known As:
Hageman Factor; Coagulation Factor XII; Blood-coagulation factor XII
Networked: 458
relevant articles (8 outcomes,
38 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Renné, Thomas:
24 articles
(09/2015 - 07/2005)
|
2. | Gailani, David:
12 articles
(03/2014 - 07/2005)
|
3. | Kleinschnitz, Christoph:
9 articles
(01/2014 - 03/2006)
|
4. | Nieswandt, Bernhard:
9 articles
(02/2012 - 07/2005)
|
5. | Bork, Konrad:
7 articles
(01/2015 - 05/2006)
|
6. | Stoll, Guido:
7 articles
(02/2012 - 03/2006)
|
7. | Björkqvist, Jenny:
5 articles
(08/2015 - 02/2011)
|
8. | Maas, Coen:
5 articles
(08/2015 - 09/2008)
|
9. | Tucker, Erik I:
5 articles
(03/2014 - 01/2009)
|
10. | McCarty, Owen J T:
5 articles
(03/2014 - 01/2009)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures